Correction: Patient Experience with 10 mg Intranasally Administered Zavegepant as an Acute Treatment of Migraine Attacks: Qualitative Research Findings.
- DOI
- 10.1007/s40120-026-01034-7
- Published
- 2026 Sep 25
- Container
- Neurology and therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40120-026-01034-7,
title = {Correction: Patient Experience with 10 mg Intranasally Administered Zavegepant as an Acute Treatment of Migraine Attacks: Qualitative Research Findings.},
author = {Rosen N and Moran H and Coulter J and Kissling A and You W and Kopenhafer L and Beusterien K and Isaacs J and Nakajima K and Cirillo J and Sweeney S},
year = {2026},
journal = {Neurology and therapy},
doi = {10.1007/s40120-026-01034-7},
url = {https://doi.org/10.1007/s40120-026-01034-7}
}RIS
TY - JOUR TI - Correction: Patient Experience with 10 mg Intranasally Administered Zavegepant as an Acute Treatment of Migraine Attacks: Qualitative Research Findings. AU - Rosen N AU - Moran H AU - Coulter J AU - Kissling A AU - You W AU - Kopenhafer L AU - Beusterien K AU - Isaacs J AU - Nakajima K AU - Cirillo J AU - Sweeney S PY - 2026 JO - Neurology and therapy DO - 10.1007/s40120-026-01034-7 UR - https://doi.org/10.1007/s40120-026-01034-7 ER -
APA
N, R., H, M., J, C., A, K., W, Y., L, K., K, B., J, I., K, N., J, C., & S, S. (2026). Correction: Patient Experience with 10 mg Intranasally Administered Zavegepant as an Acute Treatment of Migraine Attacks: Qualitative Research Findings.. Neurology and therapy. https://doi.org/10.1007/s40120-026-01034-7
Source records
- pubmed · retrieved 2026-09-26T00:49:53.014Z